Development of a Weighted Cardiometabolic Disease Staging (CMDS) System for the Prediction of Future Diabetes
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
CONTEXT: Metabolic syndrome traits are important risk factors for diabetes; however, each trait has different predictive power for future diabetes. Additionally, the impact of insulin resistance on metabolic profile can differ by gender and racial group, suggesting that gender-race specific prediction algorithms for diabetes may be warranted. OBJECTIVE: To develop a quantitative scoring system based on weighting of risk components in the cardiometabolic disease staging (CMDS) system for the prediction of future diabetes. DESIGN, SETTING, AND PARTICIPANTS: We derived the CMDS score in 2857 participants with valid follow-up information on incident diabetes from the Coronary Artery Risk Development in Young Adults study and validated it in 6425 older participants from the Atherosclerosis Risk in Communities study. We assigned a simple integer value for each CMDS risk factor component. MAIN OUTCOME MEASURES: Incident diabetes. RESULTS: Fasting glucose, 2-hour glucose, waist circumference, and blood pressure components contributed similarly for the prediction of future diabetes (CMDS scores, 23, 21, 26, and 20, respectively). The area under the receiver operating characteristic curve was 0.7158 for the CMDS scoring system, whereas it was 0.7053 for the Framingham diabetes score. The CMDS components performed differently for prediction of future diabetes in Black and White men and women. The components with the highest predictive power for diabetes were waist circumference in Black men, 2-hour glucose in Black women, and fasting glucose in both White men and White women. CONCLUSIONS: The weighted CMDS score has high model discrimination power for diabetes and can be used clinically to identify patients for weight loss therapy based on differential risk for future diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The at-risk pool of persons at risk of T2D is large,878,879 and it is not feasible or safe to treat all persons aggressively using all the tools of obesity medicine.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [878]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The CMDS and ACC/AHA models were selected over the Framingham models due to their broader generalisability across populations and greater accuracy of prediction. 30 , 34”
From Tirzepatide and the 10‐year predicted risk of cardiovascular disease and type 2 diabetes in adults with obesity and prediabetes: A post hoc analysis from the three‐year SURMOUNT ‐1 trial (2025) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2014) · JAMA · doi:10.1001/jama.2014.732 · Cited by 8,072 · cited 1×
“However, with nearly 70% of US adults being overweight or obese (6), and due to concerns of safety and cost, it is impracticable to treat all overweight and obese subjects with medical or surgical therapy.”
Background
Cited by
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Self-citationMetabolically healthy obesity: facts and fantasies
Smith, G. I., Mittendorfer, B., & Klein, S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129186 · Cited by 645
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationMechanick, J. I., Garber, A. J., Grunberger, G., Handelsman, Y., & Garvey, W. T. (2018) · Endocrine Practice · doi:10.4158/ps-2018-0139 · Cited by 104
Self-citationTHE CONCEPT OF NOVEL NATIONAL CLINICAL GUIDELINES ON OBESITY
Shlyakhto, E. V., Nedogoda, S. V., Конради, А. О., Баранова, Е. И., Fomin, V. V., Vertkin, A. L., & Chumakova, G. A. (2016) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2016-4-7-13 · Cited by 76
Phạm, Q., Gamble, A., Hearn, J., & Cafazzo, J. A. (2021) · Journal of Medical Internet Research · doi:10.2196/22320 · Cited by 56
Wilkinson, L., Yi, N., Mehta, T., Judd, S., & Garvey, W. T. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003232 · Cited by 47
Self-citationFarkas, G. J., Burton, A. M., McMillan, D. W., Sneij, A. M., & Gater, D. R. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12071088 · Cited by 50
VISCERAL ADIPOSITY AS A GLOBAL FACTOR OF CARDIOVASCULAR RISK
Chumakova, G. A., Kuznetsova, Т. Y., Druzhilov, М. A., & Veselovskaya, N. G. (2018) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2018-5-7-14 · Cited by 54
Yahiro, A. M., Wingo, B. C., Kunwor, S., Parton, J., & Ellis, A. C. (2019) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2018.1557864 · Cited by 41
Guo, F., & Garvey, W. T. (2017) · Diabetes Care · doi:10.2337/dc17-0088 · Cited by 37
Self-citationClinical Definition of Overweight and Obesity
Garvey, W. T. (2018) · Springer eBooks · doi:10.1007/978-3-319-95655-8_7 · Cited by 46
Self-citationDiabetes risk assessment with imaging: a radiomics study of abdominal CT
Lu, C., Wang, Y., Meng, X., Zhao, H.-T., Zeng, C. H., Xu, W., Gao, Y., & Ju, S. (2018) · European Radiology · doi:10.1007/s00330-018-5865-5 · Cited by 32
Howell, C. R., Zhang, L., Mehta, T. S., Wilkinson, L., Carson, A. P., Levitan, E. B., Cherrington, A., Yi, N., & Garvey, W. T. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.100868 · Cited by 39
Self-citationObesity and cardiometabolic disease — more than meets the eye
Aslibekyan, S. W., & Garvey, W. T. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.112 · Cited by 21
Self-citationHowell, C. R., Zhang, L., Yi, N., Mehta, T. S., Cherrington, A., & Garvey, W. T. (2022) · Obesity · doi:10.1002/oby.23440 · Cited by 20
“All rights reserved system using presence and severity of metabolic syndrome traits (15) to predict incident diabetes and cardiovascular disease mortality.”
BackgroundMethodSelf-citationHankosky, E. R., Lebrec, J., Lee, C. J., Dimitriadis, G. K., Jouravskaya, I., Stefanski, A., & Garvey, W. T. (2025) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.70143 · Cited by 17
“30,34 The PREVENT model is sex-specific, independent of race, and incorporates renal function in its analyses.”
Self-citationHEART REMODELING IN OVERWEIGHT AND OBESITY WITH CARDIAC COMORBIDITIES
Логачева, И. В., Ryazanova, Т. A., Makarova, V. R., Avzalova, F. R., & Максимов, Н. И. (2017) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2017-4-40-46 · Cited by 18
NATIONAL CLINICAL RECOMMENDATIONS FOR OBESITY: CONCEPT AND PROSPECTS
Nedogoda, S. V., Barykina, I. N., & Salasyuk, A. S. (2017) · Journal of Volgograd State Medical University · doi:10.19163/1994-9480-2017-1(61)-134-140 · Cited by 17
“Guo F., Garvey W. T. Development of a Weighted Cardiometabolic Disease Staging (CMDS) System for the Prediction of Future Diabetes // The Journal of Clinical Endocrinology & Metabolism.”
InfluentialEjima, K., Xavier, N., & Mehta, T. S. (2020) · Obesity · doi:10.1002/oby.22656 · Cited by 18
“For that reason, they provided gender- and race-specific CMDS scores as well (39).”
BackgroundRace Versus Social Determinants of Health in COVID-19 Hospitalization Prediction
Howell, C. R., Zhang, L., Yi, N., Mehta, T. S., Garvey, W. T., & Cherrington, A. (2022) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2022.01.034 · Cited by 16
Self-citationNieto-Martínez, R. E., Gonzalez-Rivas, J. P., Ugel, E., BRAJKOVICH, I. E., Rísquez, A., Garvey, W. T., & Mechanick, J. I. (2017) · Endocrine Practice · doi:10.4158/ep161644.or · Cited by 13
“needed to assess risk for diabetes and cardiovascular disease in order to target high risk patients for weight loss therapy.(19,27) Given the high prevalence of overweight and obesity, CMDS and the AACE/ACE staging paradigm for ORCs could be used as a guide to a rational strategy for diabetes prevention based on benef…”
MethodSelf-citationSkin microvascular change in men with normal arterial pressure depending on body mass index
Korolev, A. I., Александрович, Ф. А., Gorshkov, A. Y., Mikhailova, M. A., Дадаева, В. А., Vasilyev, D. K., Akasheva, D. U., & Drapkina, O. M. (2020) · Russian Journal of Preventive Medicine · doi:10.17116/profmed202023051144 · Cited by 9
Candi, E., Campanelli, M., Sica, G. S., Schinzari, F., Rovella, V., Daniele, N. D., Melino, J., & Tesauro, M. (2021) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2020.100077 · Cited by 11
The diagnosis and evaluation of patients with obesity
Garvey, W. T. (2018) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2018.10.001 · Cited by 11
Self-citationHowell, C. R., Tanaka, S., Zhang, L., Carson, A. P., Yi, N., Shikany, J. M., Garvey, W. T., & Cherrington, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16241 · Cited by 6
“21,27 The CMDS is measured at baseline and uses continuous clinical measures 22 – specifically, fasting blood glucose, body mass index (BMI), blood pressure, high-density lipoprotein cholesterol (HDL-c) and tri-glycerides.”
InfluentialSelf-citationChannabasavaraju, B. D., & Vinayakamurthy, U. (2020) · Journal of Computer Science · doi:10.3844/jcssp.2020.105.116 · Cited by 6
“But, definitely the selection of significant features will improve the prediction accuracy, which proved that the necessary of identifying the significant features is important to achieve the goal (Guo and Garvey, 2015; Cui et al ., 2018; Bindushree, 2016; Bindushree and Rani, 2017).”
BackgroundMetabolically healthy obesity: it is time to consider its dynamic changes
Cho, Y. K., & Jung, C. H. (2022) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2022.4.e19 · Cited by 5
Singh, A., & Bruemmer, D. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.100867 · Cited by 7
университет, Б. Г. Н. И., Голивец, Т. П., Dubonosova, D. G., университет, Б. Г. Н. И., Likrizon, S. V., & университет, Б. Г. Н. И. (2023) · Актуальные проблемы медицины · doi:10.52575/2687-0940-2023-46-2-123-143 · Cited by 6
Ahmed, A. Y., & Sayed, A. M. (2016) · Current Pediatric Research · Cited by 5
Response to “The Future of Obesity Diagnostic Coding”
Garvey, W. T., & Mechanick, J. I. (2020) · Obesity · doi:10.1002/oby.22815 · Cited by 3
Self-citationCardiac Structure and Function in Young Adults With Various Cardiometabolic Profiles
PARVE, S. D., & Синеглазова, А. В. (2023) · Cureus · doi:10.7759/cureus.40524 · Cited by 2
“Cardiometabolic risk was evaluated based on the presence of risk factors, and patients were categorized according to the CMDS system [26,27].”
MethodKarabukayeva, A., Anderson, J. L., Hall, A. G., Feldman, S. S., & Mehta, T. S. (2022) · JMIR Formative Research · doi:10.2196/37456 · Cited by 2
“Furthermore, BMI is the most preferred screening tool, though literature indicates it could be a poor indicator of cardiovascular disease and overall mortality risk [7,15].”
BackgroundHYPERTENSION AND DIABETES MELLITUS TYPE 2
Стаценко, М. Е., & Derevyanchenko, M. V. (2018) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2018-14-2-217-222 · Cited by 1
Saito, I. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.89.2015.tde-17112015-170114
Thirteenth World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease
Krentz, A. J. (2016) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000074
Evaluation and Treatment of Insulin Resistance and Hyperglycemic States
Hurley, D. L., & Zangeneh, F. (2018) · Springer eBooks · doi:10.1007/978-3-319-95655-8_13
PARVE, S. D., & Sineglazova, A. V. (2022) · Современные проблемы науки и образования · doi:10.17513/spno.31712
Effects of SGLT2 (Sodium-Dependent Type 2 Glucose Transporters) on Different Systems
Universidad Autónoma de Querétaro. Querétaro, M., Dorantes, M. Á. S., Medrano, M. E. B., Ortega, F. G., Hernández, O. A. A., Universidad Autónoma de Querétaro. Querétaro, M., Flores, M. E. V., Universidad Autónoma de Guadalajara. Guadalajara, M., Franco, L. B. S., & Universidad Autónoma de Guadalajara. Guadalajara, M. (2023) · International Journal of Medical Science and Clinical Research Studies · doi:10.47191/ijmscrs/v3-i5-07
Xue, J., Anderson, J., Huang, A., Gou, R. Y., Sun, H., Zhao, J., Allende, C., Hua, H., Hohlbauch, A., & Chinthammit, C. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70999
Shinde, S., Kahles, F., Vasileva-Metodiev, S. Z., Griffin, R. M., Liu‐Seifert, H., Lebrec, J., Xavier, N., Li, R., Klise, S. R., Singh, A., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71322 · Cited by 1
Zhang, L., Cui, J., Saleem, M., Burkholder, G., Johnson, R. D., Montgomery, A. P., Levitan, E. B., Erdmann, N., Lund, F. E., Garvey, W. T., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113578
Self-citation
Metadata
- Authors
- Guo, F., & Garvey, W. T.
- Affiliations
- University of Alabama at Birmingham (US)
- Corresponding author
- Guo, Fangjian
- Garvey, W. Timothy
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-10
- Volume
- 100
- Issue
- 10
- Pages
- 3871-3877
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4596035
- OpenAlex
- W1866702143
- Cited by
- 44
- References
- 42
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 7 · 2021: 2 · 2020: 5 · 2019: 2 · 2018: 7 · 2017: 6 · 2016: 4 · 2015: 1
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01CX000432)
- National Institutes of Health (5p60dk079626-05)
- National Institute of Diabetes and Digestive and Kidney Diseases (P60-DK-079626, R01DK038765, DK038765, DK-083562, R01DK083562)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD055163)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- diabetes prediction, metabolic syndrome, risk scoring, insulin resistance, waist circumference, fasting blood glucose, 2-hour plasma glucose, blood pressure, sex differences, racial differences, black and white populations, weight loss treatment, Coronary Artery Risk Development in Young Adults, Atherosclerosis Risk in Communities Study
- MeSH terms
- Adolescent, Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Incidence, Risk Assessment, Metabolic Syndrome, Waist Circumference, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.